OOIR: Observatory of International Research

Papers

(The H4-Index of World Psychiatry is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
WPA scientific publications in the triennium 2020‐2023	739
Detecting and managing non‐suicidal self‐damaging behaviors	474
R. Spitzer and the depathologization of homosexuality: some considerations on the 50th anniversary	416
A question of continuity: a self‐determination theory perspective on “third‐wave” behavioral theories and practices	382
Evidence‐informed is not enough: digital therapeutics also need to be evidence‐based	362
Patterns and correlates of patient‐reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys	308
What is good acute psychiatric care (and how would you know)?	212
From inter‐brain connectivity to inter‐personal psychiatry	205
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta‐analysis	200
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021	191
Trauma, coloniality and survivance among Indigenous peoples in the US	180
Therapist‐supported Internet‐based cognitive behaviour therapy yields similar effects as face‐to‐face therapy for psychiatric and somatic disorders: an updated systematic review and meta‐analysis	176
Cognitive behavioral therapy, process‐based approaches, and evolution in the context of physical health	172
	163
The “Meet the WPA Council” Panel at the 21st World Congress of Psychiatry	162
Prenatal exposure to antidepressants or antipsychotics and the risk of seizure in children	161
Implementation of the WPA Action Plan 2020‐2023	155
Estimating the reproducibility of psychotherapy effects in mood and anxiety disorders: the possible utility of multicenter trials	154
Sex differences need to be considered when treating women with psychotropic drugs	153
Scientific validation of the ICD‐11 CDDR	150
Potential for prediction of psychosis and bipolar disorder in Child and Adolescent Mental Health Services: a longitudinal register study of all people born in Finland in 1987	149
Functional neurological disorder: defying dualism	124
Breaking down barriers to conversations about sexual and reproductive health	121
	119
Prevention, treatment and care of substance use disorders in times of COVID‐19	118

Alternatives to coercion in mental health care: WPA Position Statement and Call to Action	106
Achieving equality, inclusiveness, and cultural sensitivity in mental health (EDIT)	105
Mental health literacy for supporting children: the need for a new field of research and intervention	105
Burnout: a case for its formal inclusion in classification systems	96
The aggregation of marginal gains: a pragmatic philosophy of clinical care in psychiatry	93
How common is secondary psychosis? Estimates from a systematic review and meta‐analysis	93
Designing and scaling up integrated youth mental health care	92
Malpractice claims in psychiatry: approaches to reducing risk	87
One world, one profession: psychiatry	87
Key considerations for clinical trials in psychopharmacology	85
Education, policy and clinical care in mental health: an update on the activities of WPA Collaborating Centres	85
Metacognition in psychosis: a renewed path to understanding of core disturbances and recovery‐oriented treatment	78
After the acute crisis – engaging people with psychosis in rehabilitation‐oriented care	78
How the ICD‐11 and the CDDR address the public health dimensions of substance use	71
What makes Internet‐based interventions work?	63
The hypothesis of biologically based subtypes of schizophrenia: a 10‐year update	63
Augmenting trauma‐focused cognitive behavior therapy for post‐traumatic stress disorder with memory specificity training: a randomized controlled trial	63
The Hikikomori Diagnostic Evaluation (HiDE): a proposal for a structured assessment of pathological social withdrawal	61
A lived experience perspective on the new World Mental Health Report	59
“Third‐wave” cognitive and behavioral therapies and the emergence of a process‐based approach to intervention in psychiatry	58
Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis	57
Ongoing phase 2/3 trials of psychotropic drugs: is help finally on the way?	56
The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality	56
Treatment of substance use disorders in prison settings: statement by the UNODC‐WHO Informal Scientific Network, UN Commission on Narcotic Drugs	55
Meeting the challenges of the new frontier of youth mental health care	55
WPA scientific meetings 2020‐2023	52